https://news.medxy.ai/global-insights-on-implantable-cardioverter-defibrillators-in-high-risk-hypertrophic-cardiomyopathy-efficacy-and-outcomes/Medxy AIen2026-08-29T02:43:00-07:00Global Insights on Implantable Cardioverter-Defibrillators in High-Risk Hypertrophic Cardiomyopathy: Efficacy and Outcomes https://news.medxy.ai/zh/childhood-crohns-disease/Medxy AIzh2026-08-29T01:46:16-07:00儿童期接触克罗恩病同胞：肠道微生物组与疾病易感性的启示 https://news.medxy.ai/ja/childhood-crohns-exposure/Medxy AIja2026-08-29T01:45:59-07:00幼少期のクローン病患者きょうだいへの曝露が示す腸内細菌叢と発症リスクへの影響 https://news.medxy.ai/vi/early-crohn-exposure/Medxy AIvi2026-08-29T01:45:40-07:00Tiếp xúc sớm với anh/chị/em ruột mắc bệnh Crohn: ý nghĩa đối với hệ vi sinh đường ruột và nguy cơ mắc bệnh https://news.medxy.ai/zh/spondin2-gastric-progress/Medxy AIzh2026-08-29T01:39:55-07:00成纤维细胞来源的 Spondin-2：驱动胃上皮化生向异型增生进展的关键因子 https://news.medxy.ai/ja/spondin-2-gastric-transformation/Medxy AIja2026-08-29T01:39:37-07:00線維芽細胞由来Spondin-2：胃上皮における化生から異形成への進展を駆動する重要因子 https://news.medxy.ai/vi/spondin-2-fibroblast/Medxy AIvi2026-08-29T01:39:17-07:00Spondin-2 do nguyên bào sợi tiết ra: “động lực” then chốt thúc đẩy chuyển từ dị sản sang loạn sản ở biểu mô dạ dày https://news.medxy.ai/ja/68577-2/Medxy AIja2026-08-29T01:28:10-07:00ヌーナン症候群における神経画像所見と遺伝子型・表現型相関：多施設共同コホート研究の知見 https://news.medxy.ai/vi/noonan-syndrome-genetics/Medxy AIvi2026-08-29T01:27:49-07:00Tiết lộ các kiểu hình ảnh thần kinh và mối liên hệ kiểu gen – kiểu hình trong hội chứng Noonan: Góc nhìn từ một đoàn hệ đa trung tâm https://news.medxy.ai/vi/janus-kinase-inhibition/Medxy AIvi2026-08-29T01:25:40-07:00Ức chế Janus kinase: hướng điều trị mới đầy hứa hẹn cho hẹp dưới thanh môn vô căn https://news.medxy.ai/ja/pediatric-stroke-thrombolysis-2/Medxy AIja2026-08-29T01:24:30-07:00小児急性虚血性脳卒中における血栓溶解療法：適応と臨床的示唆 https://news.medxy.ai/vi/68564-2/Medxy AIvi2026-08-29T01:24:11-07:00Chỉ định tiêu sợi huyết trong đột quỵ thiếu máu cục bộ cấp tính ở trẻ em: Thực trạng, hạn chế và định hướng tương lai https://news.medxy.ai/zh/type-1-diabetes-costs/Medxy AIzh2026-08-29T01:23:18-07:001型糖尿病成年患者的经济负担与费用相关不依从：管理新挑战 https://news.medxy.ai/ja/68560-2/Medxy AIja2026-08-29T01:23:00-07:001型糖尿病の成人における経済的負担と費用に起因する服薬・治療不遵守：新たな管理上の課題 https://news.medxy.ai/vi/financial-burden-noncompliance/Medxy AIvi2026-08-29T01:22:40-07:00Gánh nặng tài chính và không tuân thủ do chi phí trong quản lý đái tháo đường týp 1 ở người lớn https://news.medxy.ai/zh/cancer-decision-burden/Medxy AIzh2026-08-29T01:21:45-07:00癌症诊疗中的决策负担：肿瘤科医生的视角与应对策略 https://news.medxy.ai/ja/cancer-treatment-support/Medxy AIja2026-08-29T01:21:30-07:00がん診療における意思決定負担をどう支えるか：腫瘍内科医の視点と対応戦略 https://news.medxy.ai/vi/decision-burden-cancer-care/Medxy AIvi2026-08-29T01:21:09-07:00Gánh nặng ra quyết định trong chăm sóc ung thư: Góc nhìn và chiến lược của bác sĩ ung thư https://news.medxy.ai/zh/neuroendocrine-cancer-insights/Medxy AIzh2026-08-29T01:20:15-07:00解码神经内分泌癌：蛋白质组学洞见揭示亚型、生物标志物与治疗新机遇 https://news.medxy.ai/ja/68550-2/Medxy AIja2026-08-29T01:19:59-07:00神経内分泌癌の解明：プロテオミクス解析が明らかにするサブタイプ、バイオマーカー、および新たな治療の可能性 https://news.medxy.ai/vi/neuroendocrine-tumor/Medxy AIvi2026-08-29T01:19:38-07:00Giải mã ung thư biểu mô thần kinh nội tiết: Những phát hiện từ proteomic xác định phân nhóm, dấu ấn sinh học và cơ hội điều trị https://news.medxy.ai/zh/pulmonary-artery-stiffness/Medxy AIzh2026-08-29T01:18:43-07:00肺动脉僵硬度与右心室功能：轻度肺动脉高压死亡风险的更优预测因子 https://news.medxy.ai/ja/pulmonary-artery-sclerosis-prognosis/Medxy AIja2026-08-29T01:18:26-07:00肺動脈硬化度と右室機能が示す予後予測力：軽症肺高血圧症における死亡リスクの有力指標 https://news.medxy.ai/vi/pulmonary-artery-stiffness-2/Medxy AIvi2026-08-29T01:18:05-07:00Độ cứng động mạch phổi và chức năng thất phải: yếu tố dự báo tử vong vượt trội trong tăng áp phổi nhẹ https://news.medxy.ai/zh/full-term-fetal-growth-impact/Medxy AIzh2026-08-29T01:17:10-07:00足月出生中胎龄与胎儿大小对婴幼儿至青春期神经发育的影响 https://news.medxy.ai/ja/68540-2/Medxy AIja2026-08-29T01:16:53-07:00満期産における在胎週数および胎児サイズが乳児期から青年期の神経発達に及ぼす影響 https://news.medxy.ai/vi/gestational-age-neurodevelopment/Medxy AIvi2026-08-29T01:16:35-07:00Ảnh hưởng của tuổi thai và kích thước thai nhi đối với phát triển thần kinh từ giai đoạn nhũ nhi đến tuổi vị thành niên https://news.medxy.ai/zh/tumor-size-prognosis-2/Medxy AIzh2026-08-29T01:15:38-07:00肿瘤大小能否预测胸腺上皮肿瘤预后？一项欧洲大队列研究给出答案 https://news.medxy.ai/ja/tumor-size-prognosis-3/Medxy AIja2026-08-29T01:15:21-07:00胸腺上皮性腫瘍の予後予測マーカーとしての腫瘍径：欧州大規模コホートからの知見 https://news.medxy.ai/vi/tumor-size-prognosis/Medxy AIvi2026-08-29T01:15:00-07:00Kích thước khối u có phải là dấu ấn tiên lượng trong các u biểu mô tuyến ức? Dữ liệu nổi bật từ một đoàn hệ lớn tại châu Âu https://news.medxy.ai/zh/mri-eoad-atrophy/Medxy AIzh2026-08-29T01:14:06-07:00MRI 识别的 EOAD 特异性萎缩：早发型轻度认知障碍的预后生物标志物 https://news.medxy.ai/ja/68530-2/Medxy AIja2026-08-29T01:13:49-07:00MRIで特定されたEOAD特異的萎縮：若年発症型軽度認知障害の予後予測バイオマーカー https://news.medxy.ai/vi/68529-2/Medxy AIvi2026-08-29T01:13:28-07:00Tình trạng teo não đặc hiệu của bệnh Alzheimer khởi phát sớm (EOAD) được xác định qua MRI: Một dấu ấn sinh học tiên lượng cho chứng suy giảm nhận thức nhẹ khởi phát sớm https://news.medxy.ai/zh/eras-improve-pediatric-surgery/Medxy AIzh2026-08-29T01:12:28-07:00ERAS显著改善儿童下尿路重建术后结局 https://news.medxy.ai/ja/68525-2/Medxy AIja2026-08-29T01:12:13-07:00ERASは、小児における下部尿路再建術後の転帰を著しく改善します https://news.medxy.ai/vi/68524-2/Medxy AIvi2026-08-29T01:11:54-07:00ERAS cải thiện đáng kể kết quả điều trị sau phẫu thuật tái tạo đường tiết niệu dưới ở trẻ em https://news.medxy.ai/zh/deep-learning-wound-analysis/Medxy AIzh2026-08-29T01:10:52-07:00借助深度学习分析伤口图像，推动切口手术部位感染的早期识别 https://news.medxy.ai/ja/deep-learning-infection-detection/Medxy AIja2026-08-29T01:10:36-07:00創部写真解析による切開部手術部位感染の早期検出に向けた深層学習の活用 https://news.medxy.ai/vi/deep-learning-wound-infection/Medxy AIvi2026-08-29T01:10:15-07:00Khai thác deep learning để phát hiện sớm nhiễm khuẩn vết mổ đường mổ qua phân tích ảnh vết thương https://news.medxy.ai/zh/icu-microbiome/Medxy AIzh2026-08-29T01:07:56-07:00重症患者微生物组：以微生物视角重塑ICU管理 https://news.medxy.ai/ja/icu-microbiome-2/Medxy AIja2026-08-29T01:07:40-07:00重症患者のマイクロバイオーム：微生物知見が変えるICUケア https://news.medxy.ai/vi/microbiome-icu-care/Medxy AIvi2026-08-29T01:07:22-07:00Hệ vi sinh vật trong bệnh nặng: Cải thiện chăm sóc ICU nhờ hiểu biết về vi sinh https://news.medxy.ai/zh/term-small-for-gestational-age/Medxy AIzh2026-08-29T01:06:25-07:00足月小于胎龄儿：估计胎儿体重生长速度对不良结局预测的增益价值并不明显 https://news.medxy.ai/ja/68505-2/Medxy AIja2026-08-29T01:06:07-07:00正期産のSGA児（在胎不当過小児）において、有害転帰の予測における推定胎児体重の増加速度の付加的価値は有意ではない https://news.medxy.ai/vi/fetal-growth-value/Medxy AIvi2026-08-29T01:05:46-07:00Giá trị bổ sung của vận tốc tăng trưởng cân nặng thai ước tính trong dự đoán kết cục bất lợi ở thai đủ tháng nhỏ so với tuổi thai https://news.medxy.ai/zh/alteplase-efficacy-weight/Medxy AIzh2026-08-29T01:04:47-07:00体重会影响阿替普酶疗效吗？——ENCHANTED试验揭示急性缺血性卒中的关键线索 https://news.medxy.ai/ja/weight-alteplase-ischemic-stroke/Medxy AIja2026-08-29T01:04:31-07:00急性虚血性脳卒中における体重とアルテプラーゼ効果：ENCHANTED試験からの示唆 https://news.medxy.ai/vi/body-weight-alteplase-effect/Medxy AIvi2026-08-29T01:04:11-07:00Cân nặng cơ thể và hiệu quả của alteplase trong đột quỵ thiếu máu cục bộ cấp: góc nhìn từ thử nghiệm ENCHANTED https://news.medxy.ai/zh/68496-2/Medxy AIzh2026-08-29T01:03:18-07:00儿童单倍型相合造血干细胞移植中的EB病毒再激活与移植后淋巴增殖性疾病：发生率、风险及临床转归 https://news.medxy.ai/ja/ebv-ptld-hsct-pediatrics/Medxy AIja2026-08-29T01:03:01-07:00小児ハプロ一致HSCTにおけるEBV再活性化とPTLD：発生率・危険因子・臨床転帰 https://news.medxy.ai/vi/ebv-activation-ptld-hsct-kids/Medxy AIvi2026-08-29T01:02:39-07:00Tái hoạt hóa EBV và PTLD sau ghép haploidentical HSCT ở trẻ em: tỷ lệ mắc, yếu tố nguy cơ và kết cục lâm sàng https://news.medxy.ai/zh/ivosidenib-idh1-study/Medxy AIzh2026-08-29T01:01:38-07:00Ivosidenib单药治疗在IDH1突变骨髓增生异常性肿瘤/综合征中显示出前景：一项2期研究 https://news.medxy.ai/ja/68485-2/Medxy AIja2026-08-29T01:01:20-07:00IDH1変異を有する骨髄異形成腫瘍／症候群に対するイボシデニブ単剤療法が有望な結果を示す：第2相試験 https://news.medxy.ai/vi/ivosidenib-therapy-idh1-cancer/Medxy AIvi2026-08-29T01:01:00-07:00Đơn trị liệu Ivosidenib cho thấy triển vọng trong u tân sinh/hội chứng loạn sản tủy mang đột biến IDH1: Nghiên cứu pha 2 https://news.medxy.ai/zh/molecular-markers-uveal-melanoma/Medxy AIzh2026-08-28T17:38:20-07:00葡萄膜黑色素瘤二次治疗中的分子标志物稳定性与演变：基于重复基因分型与NGS的研究洞见 https://news.medxy.ai/ja/uveal-melanoma-biomarkers/Medxy AIja2026-08-28T17:38:03-07:00二次治療下のぶどう膜悪性黒色腫における分子バイオマーカーの安定性と変化：再評価遺伝子プロファイリングとNGSからの示唆 https://news.medxy.ai/vi/molecular-biomarkers-evolution/Medxy AIvi2026-08-28T17:37:44-07:00Độ ổn định và tiến hóa của các dấu ấn sinh học phân tử trong u hắc tố màng bồ đào dưới điều trị thứ phát: Góc nhìn từ đánh giá di truyền lặp lại và NGS https://news.medxy.ai/zh/adjuvant-chemotherapy-cholangiocarcinoma/Medxy AIzh2026-08-28T17:36:42-07:00远端胆管癌辅助化疗：来自德国癌症登记真实世界数据的启示 https://news.medxy.ai/ja/distal-bile-duct-cancer-chemotherapy/Medxy AIja2026-08-28T17:36:26-07:00遠位胆管癌に対する術後補助化学療法：ドイツがん登録の実臨床データから得られた知見 https://news.medxy.ai/vi/adjuvant-chemotherapy-bile-duct-cancer/Medxy AIvi2026-08-28T17:36:08-07:00Hóa trị bổ trợ trong ung thư ống mật đoạn xa: Góc nhìn từ dữ liệu thực tế của cơ quan đăng ký ung thư Đức https://news.medxy.ai/zh/dna-methylation-leukemia/Medxy AIzh2026-08-28T17:35:17-07:00DNA 甲基化特征助力提升急性髓系白血病预后评估准确性 https://news.medxy.ai/ja/dna-methylation-leukemia-2/Medxy AIja2026-08-28T17:35:01-07:00DNAメチル化シグネチャーで急性骨髄性白血病の予後予測を高める https://news.medxy.ai/vi/dna-methylation-prognosis/Medxy AIvi2026-08-28T17:34:42-07:00Nâng cao độ chính xác tiên lượng trong bệnh bạch cầu cấp dòng tủy nhờ các chữ ký methyl hóa DNA https://news.medxy.ai/zh/soquelitinib-itk-trial/Medxy AIzh2026-08-28T17:33:45-07:00靶向ITK的新希望：Soquelitinib在复发/难治性T细胞淋巴瘤中的Ⅰ期试验 https://news.medxy.ai/ja/soquelitinib-tcell-lymphoma/Medxy AIja2026-08-28T17:33:29-07:00再発・難治性T細胞リンパ腫に挑むsoquelitinib：ITK標的第1相試験の有望性 https://news.medxy.ai/zh/nk-t-lymphoma-ecology/Medxy AIzh2026-08-28T17:32:14-07:00解析结外 NK/T 细胞淋巴瘤的髓系生态位：预后相关的空间异质性图谱 https://news.medxy.ai/ja/nk-t-cell-lymphoma/Medxy AIja2026-08-28T17:31:57-07:00節外性NK/T細胞リンパ腫の予後を規定する骨髄系ニッチ：空間解析が明らかにした新知見 https://news.medxy.ai/vi/nk-t-lymphoma-map/Medxy AIvi2026-08-28T17:31:37-07:00Bản đồ dòng tủy khác biệt hé lộ các “ổ” tiên lượng trong u lympho tế bào NK/T ngoài hạch https://news.medxy.ai/ja/glaucoma-risk-test/Medxy AIja2026-08-28T17:30:37-07:00診察室眼圧が安定でも見逃される緑内障進行リスク：IOP負荷試験の意義 https://news.medxy.ai/ja/68053-2/Medxy AIja2026-08-28T17:08:00-07:00甲状腺眼症に対するテプロツムマブとグルココルチコイド静注療法の比較：日本人を対象としたMRI研究からの知見 https://news.medxy.ai/zh/energy-restriction-gestational-diabetes-2/Medxy AIzh2026-08-28T14:01:12-07:00妊娠晚期能量限制对妊娠期糖尿病母婴体成分的影响：DiGest随访研究见解 https://news.medxy.ai/vi/68351-2/Medxy AIvi2026-08-28T14:00:32-07:00Ảnh hưởng của việc hạn chế năng lượng trong giai đoạn cuối thai kỳ đối với thành phần cơ thể của mẹ và trẻ ở thai phụ mắc đái tháo đường thai kỳ: Những hiểu biết từ nghiên cứu theo dõi DiGest https://news.medxy.ai/zh/cpvl-pigr-cardiotoxicity/Medxy AIzh2026-08-28T13:59:30-07:00血浆生物标志物CPVL与PIGR可预测血液肿瘤患者蒽环类心脏毒性 https://news.medxy.ai/ja/anthracycline-cardiotoxicity-biomarkers/Medxy AIja2026-08-28T13:59:12-07:00アントラサイクリン誘発心毒性を予測する血漿バイオマーカー：CPVL と PIGR の可能性 https://news.medxy.ai/vi/cpvl-pigr-toxicity-prediction/Medxy AIvi2026-08-28T13:58:53-07:00CPVL và PIGR trong huyết tương dự đoán độc tính trên tim do anthracycline ở bệnh nhân ung thư huyết học https://news.medxy.ai/zh/heart-failure-gender-differences/Medxy AIzh2026-08-28T13:57:51-07:00射血分数降低的心力衰竭中：骨骼肌炎症与功能障碍的性别差异 https://news.medxy.ai/ja/sex-differences-muscle-inflammation/Medxy AIja2026-08-28T13:57:34-07:00駆出率低下心不全における性差別骨格筋炎症と筋機能障害 https://news.medxy.ai/vi/muscle-inflammation-heart-failure/Medxy AIvi2026-08-28T13:57:15-07:00Viêm cơ vân và rối loạn chức năng cơ khác nhau theo giới tính trong suy tim phân suất tống máu giảm https://news.medxy.ai/zh/68338-2/Medxy AIzh2026-08-28T13:56:19-07:00慢性主动脉瓣反流瓣膜置换术后的心肌纤维化与逆向重构：当前认识与临床意义 https://news.medxy.ai/ja/congenital-heart-disease-treatment/Medxy AIja2026-08-28T13:56:00-07:00先天性心疾患関連蛋白漏出性腸症に対する肝内・十二指腸周囲リンパ塞栓術の併用効果：転帰改善の可能性 https://news.medxy.ai/ja/aortic-valve-replacement/Medxy AIja2026-08-28T13:55:58-07:00慢性大動脈弁逆流における弁置換後の心筋線維化と逆リモデリング：最新知見と臨床的意義 https://news.medxy.ai/vi/68335-2/Medxy AIvi2026-08-28T13:55:32-07:00Xơ hóa cơ tim và tái cấu trúc ngược sau phẫu thuật thay van do hở van động mạch chủ mạn tính: Những hiểu biết hiện tại và ý nghĩa lâm sàng https://news.medxy.ai/ja/right-ventricle-function-3/Medxy AIja2026-08-28T13:53:00-07:00トランスサイレチンアミロイドーシス心筋症における右室機能、臨床転帰、vutrisiranの効果：HELIOS-B試験からの知見 https://news.medxy.ai/vi/right-ventricle-function-2/Medxy AIvi2026-08-28T13:53:00-07:00Chức năng thất phải, kết cục lâm sàng và tác động của vutrisiran trong amyloidosis transthyretin có bệnh cơ tim: dữ liệu từ thử nghiệm HELIOS-B https://news.medxy.ai/zh/vagus-nerve-infarction/Medxy AIzh2026-08-28T13:51:00-07:00迷走神经：心肌梗死治疗的新前沿 https://news.medxy.ai/ja/vagus-nerve-myocardial-infarction/Medxy AIja2026-08-28T13:51:00-07:00迷走神経を活かす：心筋梗塞治療の新たな地平 https://news.medxy.ai/vi/vagus-nerve-therapy/Medxy AIvi2026-08-28T13:51:00-07:00Khai thác dây thần kinh phế vị: Hướng đi mới trong xử trí nhồi máu cơ tim https://news.medxy.ai/zh/pulmonary-hypertension-risk/Medxy AIzh2026-08-28T13:50:00-07:00肺动脉高压随访中，进阶右心室表型有助于提升风险分层能力 https://news.medxy.ai/ja/risk-stratification-right-ventricle/Medxy AIja2026-08-28T13:49:00-07:00肺動脈性肺高血圧症のフォローアップにおける右室表現型解析がリスク層別化をさらに高精度化 https://news.medxy.ai/zh/community-family-intervention-hypertension/Medxy AIzh2026-08-28T13:49:00-07:00社区与家庭干预如何改善中国农村高血压控制：来自整群随机试验的启示 https://news.medxy.ai/vi/right-ventricle-phenotyping/Medxy AIvi2026-08-28T13:49:00-07:00Phân loại kiểu hình thất phải nâng cao giúp cải thiện phân tầng nguy cơ trong theo dõi tăng áp động mạch phổi https://news.medxy.ai/ja/blood-pressure-intervention/Medxy AIja2026-08-28T13:49:00-07:00中国農村部で血圧を下げる：地域・家族連携介入の効果を検証したクラスターランダム化試験 https://news.medxy.ai/vi/lowering-blood-pressure-china/Medxy AIvi2026-08-28T13:48:00-07:00Giảm huyết áp ở nông thôn Trung Quốc nhờ can thiệp cộng đồng và gia đình: bằng chứng từ một thử nghiệm ngẫu nhiên theo cụm https://news.medxy.ai/zh/liver-duodenum-embolization/Medxy AIzh2026-08-28T13:47:00-07:00联合肝内与十二指肠旁淋巴栓塞：先天性心脏病相关蛋白丢失性肠病的疗效提升 https://news.medxy.ai/vi/protein-losing-enteropathy/Medxy AIvi2026-08-28T13:47:00-07:00Kết cục cải thiện nhờ thuyên tắc bạch mạch phối hợp trong gan và quanh tá tràng ở bệnh ruột mất protein liên quan bệnh tim bẩm sinh https://news.medxy.ai/ja/pulse-field-ablation-risks-2/Medxy AIja2026-08-28T13:45:00-07:00心房細動におけるパルスフィールドアブレーションは高周波アブレーションより脳卒中・TIAリスクが高い　大規模前向きレジストリが示した安全性の新知見 https://news.medxy.ai/zh/high-risk-hcm-icd-study/Medxy AIzh2026-08-28T13:44:00-07:00高危肥厚型心肌病中植入式心律转复除颤器的全球研究：疗效与结局 https://news.medxy.ai/ja/icd-in-hcm/Medxy AIja2026-08-28T13:44:00-07:00高リスク肥大型心筋症における植込み型除細動器の国際的知見：有効性と転帰 https://news.medxy.ai/vi/icd-high-risk-hcm/Medxy AIvi2026-08-28T13:43:00-07:00ICD trong bệnh cơ tim phì đại nguy cơ cao: hiệu quả và kết cục trên phạm vi toàn cầu https://news.medxy.ai/plasma-biomarkers-cpvl-and-pigr-predict-anthracycline-induced-cardiotoxicity-in-hematologic-cancer-patients/Medxy AIen2026-08-28T11:58:35-07:00Plasma Biomarkers CPVL and PIGR Predict Anthracycline-Induced Cardiotoxicity in Hematologic Cancer Patients https://news.medxy.ai/ivosidenib-monotherapy-shows-promise-in-idh1-mutated-myelodysplastic-neoplasm-syndrome-a-phase-2-study/Medxy AIen2026-08-28T07:00:41-07:00Ivosidenib Monotherapy Shows Promise in IDH1 Mutated Myelodysplastic Neoplasm/Syndrome: A Phase 2 Study https://news.medxy.ai/adjuvant-chemotherapy-in-distal-bile-duct-carcinoma-insights-from-real-world-german-cancer-registry-data/Medxy AIen2026-08-28T06:35:50-07:00Adjuvant Chemotherapy in Distal Bile Duct Carcinoma: Insights from Real-World German Cancer Registry Data https://news.medxy.ai/enhancing-prognostic-accuracy-in-acute-myeloid-leukemia-through-dna-methylation-signatures/Medxy AIen2026-08-28T05:34:23-07:00Enhancing Prognostic Accuracy in Acute Myeloid Leukemia through DNA Methylation Signatures https://news.medxy.ai/zh/right-ventricle-function/Medxy AIzh2026-08-28T03:54:16-07:00右心室功能、临床结局与vutrisiran在合并心肌病的转甲状腺素蛋白淀粉样变性中的作用：HELIOS-B试验的新认识 https://news.medxy.ai/iop-stress-testing-identifies-glaucoma-eyes-at-risk-of-fast-progression-despite-controlled-office-pressure/Medxy AIen2026-08-28T03:29:59-07:00IOP Stress Testing Identifies Glaucoma Eyes at Risk of Fast Progression Despite Controlled Office Pressure https://news.medxy.ai/sex-specific-skeletal-muscle-inflammation-and-dysfunction-in-heart-failure-with-reduced-ejection-fraction/Medxy AIen2026-08-28T02:56:58-07:00Sex-Specific Skeletal Muscle Inflammation and Dysfunction in Heart Failure with Reduced Ejection Fraction https://news.medxy.ai/myocardial-fibrosis-and-reverse-remodeling-after-valve-replacement-in-chronic-aortic-regurgitation-advances-and-clinical-implications/Medxy AIen2026-08-28T02:55:09-07:00Myocardial Fibrosis and Reverse Remodeling After Valve Replacement in Chronic Aortic Regurgitation: Advances and Clinical Implications https://news.medxy.ai/right-ventricular-function-clinical-outcomes-and-effect-of-vutrisiran-in-transthyretin-amyloidosis-with-cardiomyopathy-insights-from-the-helios-b-trial/Medxy AIen2026-08-28T02:53:00-07:00Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Insights from the HELIOS-B Trial https://news.medxy.ai/harnessing-the-vagus-nerve-a-novel-frontier-in-myocardial-infarction-management/Medxy AIen2026-08-28T02:50:00-07:00Harnessing the Vagus Nerve: A Novel Frontier in Myocardial Infarction Management https://news.medxy.ai/advanced-right-ventricular-phenotyping-enhances-risk-stratification-in-pulmonary-arterial-hypertension-follow-up/Medxy AIen2026-08-28T02:49:00-07:00Advanced Right Ventricular Phenotyping Enhances Risk Stratification in Pulmonary Arterial Hypertension Follow-Up https://news.medxy.ai/impact-of-a-community-and-family-based-intervention-on-blood-pressure-reduction-in-rural-china-insights-from-a-cluster-randomized-trial/Medxy AIen2026-08-28T02:48:00-07:00Impact of a Community- and Family-Based Intervention on Blood Pressure Reduction in Rural China: Insights from a Cluster-Randomized Trial https://news.medxy.ai/enhanced-outcomes-with-combined-intrahepatic-and-periduodenal-lymphatic-embolization-in-congenital-heart-disease-associated-protein-losing-enteropathy/Medxy AIen2026-08-28T02:46:00-07:00Enhanced Outcomes with Combined Intrahepatic and Periduodenal Lymphatic Embolization in Congenital Heart Disease-associated Protein-Losing Enteropathy https://news.medxy.ai/higher-stroke-and-tia-risk-with-pulsed-field-ablation-compared-to-radiofrequency-ablation-in-atrial-fibrillation-insights-from-a-large-prospective-registry/Medxy AIen2026-08-28T02:45:00-07:00Higher Stroke and TIA Risk With Pulsed Field Ablation Compared to Radiofrequency Ablation in Atrial Fibrillation: Insights From a Large Prospective Registry https://news.medxy.ai/zh/pulse-field-ablation-risks/Medxy AIzh2026-08-28T01:46:00-07:00脉冲场消融较射频消融更易增加房颤患者卒中与TIA风险：大型前瞻性登记研究的新发现 https://news.medxy.ai/vi/stroke-tia-risk-rfa/Medxy AIvi2026-08-28T01:45:00-07:00Nguy cơ đột quỵ và TIA cao hơn với đốt điện trường xung so với đốt sóng cao tần trong rung nhĩ: Dữ liệu từ một cơ sở đăng ký tiến cứu quy mô lớn https://news.medxy.ai/impact-of-third-trimester-energy-restriction-on-postnatal-maternal-and-infant-body-composition-after-gestational-diabetes-insights-from-the-digest-follow-up-study/Medxy AIen2026-08-28T01:34:19-07:00Impact of Third-Trimester Energy Restriction on Postnatal Maternal and Infant Body Composition After Gestational Diabetes: Insights from the DiGest Follow-up Study https://news.medxy.ai/divergent-roles-of-il-12p40-and-il-18-in-severe-fibrosing-chronic-graft-versus-host-disease-implications-for-immunity-and-post-transplant-outcomes/Medxy AIen2026-08-28T01:32:48-07:00Divergent Roles of IL-12p40 and IL-18 in Severe Fibrosing Chronic Graft-versus-Host Disease: Implications for Immunity and Post-Transplant Outcomes https://news.medxy.ai/navigating-ethical-challenges-in-pediatric-endocrinology-case-based-approaches-and-principles/Medxy AIen2026-08-28T01:29:11-07:00Navigating Ethical Challenges in Pediatric Endocrinology: Case-Based Approaches and Principles https://news.medxy.ai/unveiling-neuroimaging-patterns-and-genotype-phenotype-links-in-noonan-syndrome-insights-from-a-multicenter-cohort/Medxy AIen2026-08-28T01:27:30-07:00Unveiling Neuroimaging Patterns and Genotype-Phenotype Links in Noonan Syndrome: Insights from a Multicenter Cohort https://news.medxy.ai/head-trauma-induced-superior-semicircular-canal-dehiscence-syndrome-a-case-series-and-review/Medxy AIen2026-08-28T01:26:49-07:00Head Trauma-Induced Superior Semicircular Canal Dehiscence Syndrome: A Case Series and Review https://news.medxy.ai/exploring-janus-kinase-inhibition-as-a-novel-therapeutic-avenue-in-idiopathic-subglottic-stenosis/Medxy AIen2026-08-28T01:25:24-07:00Exploring Janus Kinase Inhibition as a Novel Therapeutic Avenue in Idiopathic Subglottic Stenosis https://news.medxy.ai/expanding-horizons-eligibility-and-implications-of-thrombolysis-in-pediatric-acute-ischemic-stroke/Medxy AIen2026-08-28T01:23:52-07:00Expanding Horizons: Eligibility and Implications of Thrombolysis in Pediatric Acute Ischemic Stroke https://news.medxy.ai/financial-toxicity-and-cost-related-nonadherence-challenges-in-adult-type-1-diabetes-management/Medxy AIen2026-08-28T01:22:23-07:00Financial Toxicity and Cost-Related Nonadherence: Challenges in Adult Type 1 Diabetes Management https://news.medxy.ai/navigating-the-decision-making-burden-in-cancer-care-oncologists-perspectives-and-strategies/Medxy AIen2026-08-28T01:20:52-07:00Navigating the Decision-Making Burden in Cancer Care: Oncologists’ Perspectives and Strategies https://news.medxy.ai/decoding-neuroendocrine-carcinomas-proteomic-insights-define-subtypes-biomarkers-and-therapeutic-opportunities/Medxy AIen2026-08-28T01:19:22-07:00Decoding Neuroendocrine Carcinomas: Proteomic Insights Define Subtypes, Biomarkers, and Therapeutic Opportunities https://news.medxy.ai/pulmonary-artery-stiffness-and-right-ventricular-function-a-superior-predictor-of-mortality-in-mild-pulmonary-hypertension/Medxy AIen2026-08-28T01:17:47-07:00Pulmonary Artery Stiffness and Right Ventricular Function: A Superior Predictor of Mortality in Mild Pulmonary Hypertension https://news.medxy.ai/impact-of-gestational-age-and-fetal-size-on-neurodevelopment-from-infancy-through-adolescence/Medxy AIen2026-08-28T01:16:17-07:00Impact of Gestational Age and Fetal Size on Neurodevelopment from Infancy through Adolescence https://news.medxy.ai/tumor-size-as-a-prognostic-marker-in-thymic-epithelial-tumors-insights-from-a-large-european-cohort/Medxy AIen2026-08-28T01:14:43-07:00Tumor Size as a Prognostic Marker in Thymic Epithelial Tumors: Insights from a Large European Cohort https://news.medxy.ai/mri-derived-eoad-signature-atrophy-as-a-prognostic-biomarker-in-early-onset-mild-cognitive-impairment/Medxy AIen2026-08-28T01:13:10-07:00MRI-Derived EOAD-Signature Atrophy as a Prognostic Biomarker in Early-Onset Mild Cognitive Impairment https://news.medxy.ai/enhanced-recovery-after-surgery-eras-improves-outcomes-in-pediatric-lower-urinary-tract-reconstruction/Medxy AIen2026-08-28T01:11:36-07:00Enhanced Recovery After Surgery (ERAS) Improves Outcomes in Pediatric Lower Urinary Tract Reconstruction https://news.medxy.ai/harnessing-deep-learning-for-early-detection-of-incisional-surgical-site-infections-through-wound-image-analysis/Medxy AIen2026-08-28T01:09:54-07:00Harnessing Deep Learning for Early Detection of Incisional Surgical Site Infections Through Wound Image Analysis https://news.medxy.ai/the-microbiome-in-critical-illness-transforming-icu-care-through-microbial-insights/Medxy AIen2026-08-28T01:07:05-07:00The Microbiome in Critical Illness: Transforming ICU Care Through Microbial Insights https://news.medxy.ai/evaluating-the-added-value-of-estimated-fetal-weight-growth-velocity-in-predicting-adverse-outcomes-among-term-small-for-gestational-age-fetuses/Medxy AIen2026-08-28T01:05:26-07:00Evaluating the Added Value of Estimated Fetal Weight Growth Velocity in Predicting Adverse Outcomes Among Term Small-for-Gestational-Age Fetuses https://news.medxy.ai/body-weight-and-alteplase-efficacy-in-acute-ischemic-stroke-insights-from-the-enchanted-trial/Medxy AIen2026-08-28T01:03:52-07:00Body Weight and Alteplase Efficacy in Acute Ischemic Stroke: Insights from the ENCHANTED Trial https://news.medxy.ai/epstein-barr-virus-reactivation-and-ptld-in-pediatric-haploidentical-hsct-incidence-risks-and-clinical-outcomes/Medxy AIen2026-08-28T01:02:21-07:00Epstein-Barr Virus Reactivation and PTLD in Pediatric Haploidentical HSCT: Incidence, Risks, and Clinical Outcomes https://news.medxy.ai/early-childhood-exposure-to-crohns-disease-affected-siblings-implications-for-gut-microbiome-and-disease-susceptibility/Medxy AIen2026-08-28T00:45:20-07:00Early Childhood Exposure to Crohn’s Disease-Affected Siblings: Implications for Gut Microbiome and Disease Susceptibility https://news.medxy.ai/fibroblast-derived-spondin-2-a-key-driver-of-metaplasia-to-dysplasia-progression-in-gastric-epithelium/Medxy AIen2026-08-28T00:38:57-07:00Fibroblast-Derived Spondin-2: A Key Driver of Metaplasia-to-Dysplasia Progression in Gastric Epithelium https://news.medxy.ai/targeting-itk-with-soquelitinib-a-promising-phase-1-trial-in-relapsed-refractory-t-cell-lymphomas/Medxy AIen2026-08-28T00:32:53-07:00Targeting ITK with Soquelitinib: A Promising Phase 1 Trial in Relapsed/Refractory T Cell Lymphomas https://news.medxy.ai/distinct-myeloid-landscapes-define-prognostic-niches-in-extranodal-nk-t-cell-lymphoma/Medxy AIen2026-08-28T00:31:19-07:00Distinct Myeloid Landscapes Define Prognostic Niches in Extranodal NK/T-Cell Lymphoma https://news.medxy.ai/ja/energy-restriction-gestational-diabetes-3/Medxy AIja2026-08-27T18:34:59-07:00妊娠糖尿病における妊娠後期のエネルギー制限は母児の身体組成にどう影響するか：DiGest追跡研究からの知見 https://news.medxy.ai/zh/teprotumumab-vs-steroids/Medxy AIzh2026-08-27T17:08:00-07:00teprotumumab 与静脉糖皮质激素治疗甲状腺眼病的比较：来自日本 MRI 研究的启示 https://news.medxy.ai/vi/68051-2/Medxy AIvi2026-08-27T17:07:00-07:00So sánh Teprotumumab và Glucocorticoid đường tĩnh mạch trong điều trị bệnh mắt do tuyến giáp: Những hiểu biết từ một nghiên cứu MRI tại Nhật Bản https://news.medxy.ai/zh/plasma-pomc-biomarker/Medxy AIzh2026-08-27T17:06:00-07:00血浆POMC：预测无功能性垂体瘤中静止性促肾上腺皮质激素细胞腺瘤的新型生物标志物 https://news.medxy.ai/ja/plasma-pomc-pituitary-adenoma/Medxy AIja2026-08-27T17:06:00-07:00血漿POMCは非機能性下垂体腺腫におけるサイレント・コルチコトロフ腺腫の予測バイオマーカーとなるか https://news.medxy.ai/vi/pomc-biomarker-pituitary-tumor/Medxy AIvi2026-08-27T17:06:00-07:00POMC huyết tương: dấu ấn sinh học dự đoán u tuyến corticotroph im lặng trong u tuyến yên không hoạt động https://news.medxy.ai/zh/mdadi-thresholds/Medxy AIzh2026-08-27T17:05:00-07:00MDADI综合评分阈值：高效筛查头颈癌患者吞咽障碍的新思路 https://news.medxy.ai/ja/68036-2/Medxy AIja2026-08-27T17:05:00-07:00MDADI複合スコアの閾値：頭頸部がん患者における嚥下障害の効率的なスクリーニングに向けた新たなアプローチ https://news.medxy.ai/vi/68035-2/Medxy AIvi2026-08-27T17:04:00-07:00Ngưỡng điểm tổng hợp MDADI: Một phương pháp mới giúp sàng lọc hiệu quả chứng khó nuốt ở bệnh nhân ung thư vùng đầu cổ https://news.medxy.ai/zh/robotic-liver-donor-study/Medxy AIzh2026-08-27T17:04:00-07:00机器人活体供者肝切除术：关于供者生活质量与心理社会结局的1年前瞻性研究 https://news.medxy.ai/ja/robot-assisted-liver-donor-surgery/Medxy AIja2026-08-27T17:03:00-07:00ロボット支援下生体ドナー肝切除術：ドナーの生活の質と心理社会的転帰を1年間追跡した前向き研究 https://news.medxy.ai/vi/robotic-liver-donation/Medxy AIvi2026-08-27T17:03:00-07:00Cắt gan người hiến bằng robot: Những phát hiện tiền cứu trong 1 năm về chất lượng cuộc sống và kết cục tâm lý – xã hội của người hiến https://news.medxy.ai/ja/67954-2/Medxy AIja2026-08-27T16:52:00-07:00新規経口オレキシン2受容体作動薬Alixorexton、1型ナルコレプシーにおいて有望な安全性と有効性を示す：Vibrance-1第2相試験からの知見 https://news.medxy.ai/vi/67952-2/Medxy AIvi2026-08-27T16:52:00-07:00Alixorexton – một chất chủ vận thụ thể Orexin 2 dạng uống mới – cho thấy độ an toàn và hiệu quả đầy hứa hẹn trong điều trị chứng ngủ rũ loại 1: Những thông tin từ thử nghiệm lâm sàng giai đoạn 2 Vibrance-1 https://news.medxy.ai/ja/adult-obesity-guidelines/Medxy AIja2026-08-27T16:51:00-07:00成人の過体重・肥満管理：2025年VA/DoD臨床実践ガイドラインの重要アップデート https://news.medxy.ai/zh/tumor-reconstruction-comparison/Medxy AIzh2026-08-27T16:48:00-07:00巨乳症中的肿瘤整形重建与乳房缩小术：安全性、满意度与美学效果的比较 https://news.medxy.ai/ja/ai-lc-oct-basal-cell-carcinoma/Medxy AIja2026-08-27T16:38:00-07:00AI支援LC-OCTによる無症候性基底細胞癌の早期発見：最新エビデンスと臨床展望 https://news.medxy.ai/zh/early-rbc-transfusion/Medxy AIzh2026-08-27T16:36:00-07:00癌症合并脓毒性休克中的早期红细胞输注策略：TRANSPORT随机对照试验带来的启示 https://news.medxy.ai/ja/early-rbc-transfusion-2/Medxy AIja2026-08-27T16:36:00-07:00がん患者の敗血症性ショックにおける早期赤血球輸血戦略：TRANSPORT無作為化比較試験から得られた知見 https://news.medxy.ai/vi/early-blood-transfusion/Medxy AIvi2026-08-27T16:35:00-07:00Truyền hồng cầu sớm trong sốc nhiễm khuẩn ở bệnh nhân ung thư: Những phát hiện từ thử nghiệm ngẫu nhiên có đối chứng TRANSPORT https://news.medxy.ai/ja/67863-2/Medxy AIja2026-08-27T16:34:00-07:00ステロイド抵抗性急性移植片対宿主病に対する糞便微生物叢移植：有望な新規治療戦略 https://news.medxy.ai/ja/jak-inhibitors-lymphoma-treatment-2/Medxy AIja2026-08-27T16:32:00-07:00リンパ腫と免疫合併症の治療を変えるJAK阻害薬 https://news.medxy.ai/ja/selective-laser-trabeculoplasty-2/Medxy AIja2026-08-27T16:31:00-07:00緑内障治療における選択的レーザー線維柱帯形成術：長期有効性と視野予後の検討 https://news.medxy.ai/zh/capillary-leak-heart-failure/Medxy AIzh2026-08-27T16:30:00-07:00心力衰竭中毛细血管渗漏指标的特异性评估：对临床实践的启示 https://news.medxy.ai/ja/67847-2/Medxy AIja2026-08-27T16:30:00-07:00心不全における毛細血管漏出マーカーの特異的評価：臨床診療への意義 https://news.medxy.ai/ja/67752-2/Medxy AIja2026-08-27T14:31:00-07:00糖尿病におけるApo A-Iの特定部位の糖化は、HDL機能を障害し、動脈硬化を促進する https://news.medxy.ai/vi/glycation-apoai-hdl/Medxy AIvi2026-08-27T14:30:00-07:00Glycat hóa apo AI theo từng vị trí làm suy giảm chức năng HDL và thúc đẩy xơ vữa động mạch trong đái tháo đường https://news.medxy.ai/zh/67742-2/Medxy AIzh2026-08-27T14:29:00-07:00心肌梗死幸存者坚持不同饮食模式与死亡率的关联 https://news.medxy.ai/vi/eating-patterns-mortality/Medxy AIvi2026-08-27T14:29:00-07:00Tuân thủ các mô hình ăn uống khác nhau có liên quan như thế nào đến tử vong ở người sống sót sau nhồi máu cơ tim? Tổng quan dựa trên bằng chứng https://news.medxy.ai/ja/immune-mediated-disease/Medxy AIja2026-08-27T13:56:00-07:00免疫介在性疾患と中心性漿液性脈絡網膜症：MICRoN Report 21からみた臨床的知見 https://news.medxy.ai/zh/67968-2/Medxy AIzh2026-08-27T12:54:00-07:00精神分裂症的复发轨迹与抗精神病药物停药：基于荟萃分析与当代证据的见解 https://news.medxy.ai/adult-overweight-and-obesity-management-key-updates-from-the-2025-va-dod-clinical-practice-guideline/Medxy AIen2026-08-27T12:49:00-07:00Adult Overweight and Obesity Management: Key Updates from the 2025 VA/DoD Clinical Practice Guideline https://news.medxy.ai/early-red-blood-cell-transfusion-strategy-in-septic-shock-among-cancer-patients-insights-from-the-transport-randomized-controlled-trial/Medxy AIen2026-08-27T12:35:00-07:00Early Red Blood Cell Transfusion Strategy in Septic Shock Among Cancer Patients: Insights from the TRANSPORT Randomized Controlled Trial https://news.medxy.ai/ja/schizophrenia-relapse-antipsychotics/Medxy AIja2026-08-27T11:54:00-07:00統合失調症における再発経過と抗精神病薬中止：メタ解析と最新エビデンスからみた知見 https://news.medxy.ai/zh/breaking-communication-barriers/Medxy AIzh2026-08-27T11:09:00-07:00打通共享气道管理中的沟通壁垒：来自多中心麻醉科医师调查的启示 https://news.medxy.ai/discovery-of-a-novel-b-all-subtype-defined-by-ighfendrr-rearrangement-and-kras-mutations-with-poor-chemotherapy-response/Medxy AIen2026-08-27T10:12:00-07:00Discovery of a Novel B-ALL Subtype Defined by IGH::FENDRR Rearrangement and KRAS Mutations With Poor Chemotherapy Response https://news.medxy.ai/vi/antipsychotic-treatment/Medxy AIvi2026-08-27T09:54:00-07:00Quỹ đạo tái phát và ngừng thuốc chống loạn thần trong tâm thần phân liệt: Góc nhìn từ phân tích gộp và bằng chứng hiện đại https://news.medxy.ai/fecal-microbiota-transplantation-a-promising-therapy-for-steroid-refractory-acute-graft-versus-host-disease/Medxy AIen2026-08-27T09:33:00-07:00Fecal Microbiota Transplantation: A Promising Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease https://news.medxy.ai/ja/67832-2/Medxy AIja2026-08-27T09:25:00-07:00脳損傷後の意識障害におけるグルコースおよびメチオニン代謝：探索的縦断PET研究 https://news.medxy.ai/evaluating-the-impact-of-the-mission-act-on-va-specialty-care-referrals-and-wait-times-a-national-cohort-study/Medxy AIen2026-08-27T08:42:00-07:00Evaluating the Impact of the MISSION Act on VA Specialty Care Referrals and Wait Times: A National Cohort Study https://news.medxy.ai/zh/metabolic-signals-consciousness/Medxy AIzh2026-08-27T08:25:00-07:00脑损伤后意识障碍的代谢信号：葡萄糖与蛋氨酸PET成像的新发现 https://news.medxy.ai/zh/non-genetic-effects-ataxia/Medxy AIzh2026-08-27T07:24:00-07:00揭示遗传性共济失调中的非遗传影响：来自SCA6与SCA27B队列的启示 https://news.medxy.ai/ja/parathyroid-preservation/Medxy AIja2026-08-27T07:02:00-07:00全摘甲状腺切除における副甲状腺温存の向上：近赤外自家蛍光プローブ（PTeye）と視診の有効性 https://news.medxy.ai/ja/daratumumab-multiple-myeloma/Medxy AIja2026-08-27T07:00:00-07:00移植非適格の新規診断多発性骨髄腫におけるダラツムマブ＋レナリドミド／デキサメタゾンの長期生存 लाभ――MAIA最終解析が示す意義 https://news.medxy.ai/ja/tp53-mutation-hematopoiesis/Medxy AIja2026-08-27T06:59:00-07:00TP53変異クローン性造血が炎症性表現型を駆動し、CAR-T細胞療法後の不良転帰を予測する https://news.medxy.ai/ja/40-gene-expression-profiles/Medxy AIja2026-08-27T06:57:00-07:0040遺伝子発現プロファイル統合で予後予測がさらに精緻化　高リスク皮膚扁平上皮癌の術後放射線治療判断も支援 https://news.medxy.ai/relapse-trajectories-and-antipsychotic-discontinuation-in-schizophrenia-insights-from-a-meta-analysis-and-contemporary-evidence/Medxy AIen2026-08-27T06:53:00-07:00Relapse Trajectories and Antipsychotic Discontinuation in Schizophrenia: Insights from a Meta-Analysis and Contemporary Evidence https://news.medxy.ai/ja/cd19-car-t-cell-therapy/Medxy AIja2026-08-27T06:44:00-07:00慢性リンパ性白血病におけるCD19 CAR T細胞療法を妨げる免疫老化の重要性 https://news.medxy.ai/ja/tech-supported-meal-counseling/Medxy AIja2026-08-27T06:41:00-07:00テクノロジー支援型食事カウンセリング研修が、プライマリケア研修医の共同意思決定スキルを高める https://news.medxy.ai/ja/67888-2/Medxy AIja2026-08-27T06:39:00-07:00乾癬におけるエピジェネティックな老化の逆転：ティルドラキズマブによる52週間の影響 https://news.medxy.ai/ja/67837-2/Medxy AIja2026-08-27T06:27:00-07:00GLP1R R131Qバリアント：2型糖尿病におけるβ細胞機能の維持とGLP-1受容体作動薬（GLP-1RA）の有効性増強に向けた遺伝的鍵 https://news.medxy.ai/ja/endometrial-hyperplasia-sentinel-biopsy/Medxy AIja2026-08-27T06:22:00-07:00異型子宮内膜過形成におけるセンチネルリンパ節生検の臨床的意義：多施設コホート研究からの知見 https://news.medxy.ai/ja/atopic-dermatitis-care/Medxy AIja2026-08-27T06:19:00-07:00アトピー性皮膚炎管理におけるオンライン診療と対面診療の同等性：大規模ランダム化試験からの示唆 https://news.medxy.ai/ja/quantitative-perfusion-threshold/Medxy AIja2026-08-27T06:17:00-07:00SPY-PHI QPで可視化する定量的灌流閾値：乳房再建における乳房切除皮膚壊死予測と臨床的意義 https://news.medxy.ai/ja/67782-2/Medxy AIja2026-08-27T06:16:00-07:00眼瞼形成術における切開創の閉鎖：皮下縫合と連続縫合のどちらが優れているか？ https://news.medxy.ai/ja/67776-2/Medxy AIja2026-08-27T06:14:00-07:00駆出率低下を伴う心不全の管理最適化：4剤併用療法の遵守および継続に関するスウェーデンのレジストリからの知見 https://news.medxy.ai/optimizing-heart-failure-with-reduced-ejection-fraction-management-insights-from-swedish-registry-on-quadruple-therapy-adherence-and-persistence/Medxy AIen2026-08-27T06:13:00-07:00Optimizing Heart Failure with Reduced Ejection Fraction Management: Insights from Swedish Registry on Quadruple Therapy Adherence and Persistence https://news.medxy.ai/ja/new-b-all-subtype/Medxy AIja2026-08-27T06:12:00-07:00IGH::FENDRR再構成とKRAS変異を有する新規B-ALLサブタイプを発見―化学療法反応不良の背景にある分子機序 https://news.medxy.ai/zh/pteye-parathyroid-protection/Medxy AIzh2026-08-27T06:02:00-07:00PTeye 能否更好保护甲状旁腺？全甲状腺切除术中近红外自发荧光与肉眼识别的比较 https://news.medxy.ai/immunosenescence-as-a-key-barrier-to-cd19-car-t-cell-therapy-in-chronic-lymphocytic-leukemia/Medxy AIen2026-08-27T05:44:00-07:00Immunosenescence as a Key Barrier to CD19 CAR T-Cell Therapy in Chronic Lymphocytic Leukemia https://news.medxy.ai/vi/parathyroid-preservation-2/Medxy AIvi2026-08-27T05:01:00-07:00Tăng cường bảo tồn tuyến cận giáp trong cắt toàn bộ tuyến giáp: Hiệu quả của đầu dò autofluorescence cận hồng ngoại PTeye so với nhận diện bằng mắt thường https://news.medxy.ai/zh/daratumumab-survival-benefit/Medxy AIzh2026-08-27T05:00:00-07:00Daratumumab 联合 Lenalidomide 和 Dexamethasone 的长期生存获益：MAIA 最终分析揭示不适合移植初诊多发性骨髓瘤的新突破 https://news.medxy.ai/vi/daratumumab-benefits/Medxy AIvi2026-08-27T05:00:00-07:00Daratumumab phối hợp lenalidomide và dexamethasone mang lại lợi ích sống còn dài hạn trong đa u tủy xương mới chẩn đoán không đủ điều kiện ghép: Góc nhìn từ phân tích cuối cùng MAIA https://news.medxy.ai/zh/tp53-mutation-inflammation/Medxy AIzh2026-08-27T04:59:00-07:00TP53 突变克隆性造血驱动促炎表型，并提示 CAR T 细胞治疗后预后不良 https://news.medxy.ai/vi/tp53-mutation-car-tcell/Medxy AIvi2026-08-27T04:58:00-07:00Tạo máu dòng vô tính mang đột biến TP53 gây kiểu hình tiền viêm và dự báo kết cục xấu sau liệu pháp CAR T-cell https://news.medxy.ai/vi/40-gene-signature/Medxy AIvi2026-08-27T04:57:00-07:00Hồ sơ biểu hiện 40 gen tích hợp nâng cao độ chính xác tiên lượng và định hướng xạ trị bổ trợ trong ung thư biểu mô tế bào vảy da nguy cơ cao https://news.medxy.ai/zh/adult-obesity-management/Medxy AIzh2026-08-27T04:50:00-07:00成人超重与肥胖管理：2025年VA/DoD临床实践指南关键更新 https://news.medxy.ai/vi/67922-2/Medxy AIvi2026-08-27T04:46:00-07:00Rosiglitazone dùng tại chỗ: Một liệu pháp mới đầy tiềm năng chống xơ hóa cho chứng phù bạch huyết thứ phát https://news.medxy.ai/zh/immune-aging-barrier/Medxy AIzh2026-08-27T04:45:00-07:00免疫衰老：制约慢性淋巴细胞白血病CD19 CAR T细胞治疗的关键障碍 https://news.medxy.ai/vi/diet-consultation-training/Medxy AIvi2026-08-27T04:41:00-07:00Đào tạo tư vấn chế độ ăn có hướng dẫn bằng công nghệ nâng cao kỹ năng ra quyết định chung của bác sĩ nội trú trong chăm sóc ban đầu https://news.medxy.ai/vi/psoriasis-epigenetic-aging/Medxy AIvi2026-08-27T04:39:00-07:00Vảy nến và lão hóa biểu sinh: Tildrakizumab có thể “trẻ hóa” dấu ấn sinh học sau 52 tuần https://news.medxy.ai/zh/fecal-transplant-ghd-treatment/Medxy AIzh2026-08-27T04:34:00-07:00粪菌移植治疗激素难治性急性移植物抗宿主病：一种值得期待的新策略 https://news.medxy.ai/zh/selective-laser-trabeculoplasty/Medxy AIzh2026-08-27T04:31:00-07:00选择性激光小梁成形术在青光眼管理中的长期疗效与视野结局 https://news.medxy.ai/vi/67841-2/Medxy AIvi2026-08-27T04:28:00-07:00Tình trạng suy yếu sau khi xuất viện khỏi ICU ở người cao tuổi sống sót sau sốc nhiễm khuẩn: Các yếu tố dự báo chính và ý nghĩa lâm sàng